Oasmia Pharmaceutical AB
OASM
OASM was delisted on the 21st of August, 2019.
4 hedge funds and large institutions have $2.55M invested in Oasmia Pharmaceutical AB in 2016 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
12% less capital invested
Capital invested by funds: $2.89M → $2.55M (-$346K)
33% less funds holding
Funds holding: 6 → 4 (-2)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.83K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$657K |
| 2 |
Jane Street
New York
|
-$40K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$7K |
| 4 |
Morgan Stanley
New York
|
-$4 |
OASM Hedge Fund Activity: Q1 2016 in Review
4 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Oasmia Pharmaceutical AB (OASM) for Q1 2016, worth a combined $2.55M — down 12% from $2.89M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of OASM and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 1 added.
The largest buyer was Tower Research Capital (TRC), adding an estimated $2.83K. The largest seller was Sabby Management, cutting an estimated $657K.
- 4 institutional investors held Oasmia Pharmaceutical AB (OASM) as of Q1 2016, down from 6 in Q4 2015.
- Funds reported $2.55M of Oasmia Pharmaceutical AB stock for Q1 2016, down 12% quarter-over-quarter.
- 0 funds opened new Oasmia Pharmaceutical AB positions in Q1 2016 and 2 closed out, a net change of -2 holders.
- The largest Oasmia Pharmaceutical AB buyer in Q1 2016 was Tower Research Capital (TRC), an estimated $2.83K added.
- The largest Oasmia Pharmaceutical AB seller in Q1 2016 was Sabby Management, an estimated $657K sold.
Based on aggregated 13F filings for Q1 2016.